KR930007419B1 - Process for preparing cephalosporin derivatives - Google Patents

Process for preparing cephalosporin derivatives Download PDF

Info

Publication number
KR930007419B1
KR930007419B1 KR1019900011992A KR900011992A KR930007419B1 KR 930007419 B1 KR930007419 B1 KR 930007419B1 KR 1019900011992 A KR1019900011992 A KR 1019900011992A KR 900011992 A KR900011992 A KR 900011992A KR 930007419 B1 KR930007419 B1 KR 930007419B1
Authority
KR
South Korea
Prior art keywords
reaction
compound
tetrazol
methyl
formula
Prior art date
Application number
KR1019900011992A
Other languages
Korean (ko)
Other versions
KR920004400A (en
Inventor
강재성
박영원
채대병
Original Assignee
주식회사 삼천리제약
한치윤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 삼천리제약, 한치윤 filed Critical 주식회사 삼천리제약
Priority to KR1019900011992A priority Critical patent/KR930007419B1/en
Publication of KR920004400A publication Critical patent/KR920004400A/en
Application granted granted Critical
Publication of KR930007419B1 publication Critical patent/KR930007419B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms

Abstract

Cephalosporin derivatives of formula (II). (where M= hydrogen or natrium) and their pharmaceutically acceptable salt were prepd. by the reaction of 7-aminocephalosporanic acid and 1H- tetrazol-5-thiol in acetonitrile at anhydrous condition. In this reaction, catalyst is trifluoroboric ethylether (BF3OEt2).

Description

세팔로스포린 유도체의 제조방법Method for preparing cephalosporin derivative

본 발명은 다음 구조식(I)의 세팔로스포린산 및 그 염의 제조방법에 관한 것이다.The present invention relates to a method for preparing cephalosporin acid and salts thereof of the following formula (I).

Figure kpo00001
Figure kpo00001

상기식에서 M은 수소 또는 나트륨을 표시한다.Wherein M represents hydrogen or sodium.

상기 화합물 및 그 염은 세파만돌 나페이트(cefamandole nafate)라고 알려진 공지의 화합물로서 그람양성 또는 그람음성군에 광범위한 항균작용을 나타낸다.The compound and its salts are known compounds known as cefamandole nafate and exhibit a wide range of antimicrobial activities against gram positive or gram negative groups.

본 발명은 기존의 제조방법보다 간편한 제조공정으로 경제적이고 보다 진보된 방법을 제공하는 것을 특징으로 한다.The present invention is characterized by providing an economical and more advanced method with a simpler manufacturing process than the existing manufacturing method.

구조식(I)의 화합물을 제조하는 기존의 방법으로는 미국특허 제3,641,021호, 제3,928,592호(국내대응특허 공고번호 제80-604호), 제4,006,138호에 기술되어 있는 바와같이 7-아미노-3-(1-메틸-1H-테트라졸-5-일티오메틸)-3-세펨-4-카복실산(7-TACA)을 과량의 모노트리메틸실릴아세트아미드(MSA)로 실릴화시킨후 0-포밀만델로일 클로라이드(FMC)와 20-30℃에서 반응시켜 목적을 제조하였다. 이때 사용한 모노트리메틸실릴 아세트아미드(MSA)는 고가의 시약으로 5당량 이상을 사용하여 실릴화하였으므로 비록 수율이 80%라 할지라도 경제적이지 못하고 회수 불가능하므로 대량생산을 위한 산업화는 곤란하였다.Existing methods for preparing compounds of formula (I) include 7-amino-3 as described in US Pat. Nos. 3,641,021, 3,928,592 (Korean Patent Publication No. 80-604), 4,006,138. -(1-Methyl-1H-tetrazol-5-ylthiomethyl) -3-cepem-4-carboxylic acid (7-TACA) is silylated with excess monotrimethylsilylacetamide (MSA) followed by 0-formylman Reaction with deloyl chloride (FMC) at 20-30 ° C prepared the target. The monotrimethylsilyl acetamide (MSA) used at this time was silylated by using at least 5 equivalents as an expensive reagent, so even though the yield was 80%, it was not economical and was not recoverable.

이와같은 결점을 보완한 기술내용으로 실릴화공정을 거침이 없이 7-TACA 염산염을 삼급아미드극성용매(1-메틸-2-피롤리디논)에 용해시켜 0.2∼0.5당량의 수분제거제(트리메틸클로로실란 또는 헥사메틸디실라잔)존재하 FMC와 10-30℃에서 1-3시간 반응시켜 세파만돌 나페이트를 85%의 수율로 제조하는 방법이 국내특허 공고번호 제87-2003호로 알려져 있으나 역시 공정이 복잡하고 경제적이지 못하였다.In order to solve the above-mentioned deficiencies, 7-TACA hydrochloride is dissolved in a tertiary amide polar solvent (1-methyl-2-pyrrolidinone) without going through the silylation process, and 0.2 to 0.5 equivalents of water remover (trimethylchlorosilane Or hexamethyldisilazane) and reacted with FMC at 10-30 ° C for 1-3 hours to produce Sephamandol Naphate in 85% yield, which is known as Korean Patent Publication No. 87-2003. It was not complicated and economical.

또한, 미국특허 제3,928,334호에서는 N-에톡시카보닐-2-에톡시-1,2-디하이드로 퀴놀린 존재하 아실화하였으나 수율이 저조(71%)한 단점이 있다. 특히, 이들 방법의 주요 아실화반응은 까다로운 무수조건하 반응시키고 있다.In addition, U.S. Patent No. 3,928,334 acylates in the presence of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, but has a disadvantage of poor yield (71%). In particular, the main acylation reactions of these processes are carried out under difficult anhydrous conditions.

본 발명은 상기 선행방법보다 간편한 방법으로 실릴화 공정을 거치지 않고 유기용매와 물의 혼합용매하에서 아실화반응을 시킴으로써 목적물을 경제적으로 제조하는 새로운 방법을 제공하는 것이다.The present invention provides a new method for economically preparing the desired product by acylation reaction under a mixed solvent of organic solvent and water without going through the silylation process by a simpler method than the foregoing method.

즉, 하기 구조식(II)화합물을 물에 현탁시킨후 무기 또는 유기 염기성화합물을 가해 pH를 8-9.5로 액성을 조정하여 용해시킨후, 물과 혼화 가능한 유기용매 즉, 테트라히드로푸란, 아세토니트릴, 디메틸포름아미드 또는 디메틸아세트아미드 중 특히 아세토니트릴을 가한후, 하기 구조식(III)화합물과 아실화 반응시켜 높은 수율(약87%)로 목적물을 제조하는 새로운 방법이다.That is, the following structural formula (II) compound is suspended in water, and then an inorganic or organic basic compound is added to adjust pH to 8-9.5 to dissolve the liquid, and then dissolved in an organic solvent that is miscible with water, that is, tetrahydrofuran, acetonitrile, In particular, acetonitrile in dimethylformamide or dimethylacetamide is added, followed by acylation with a compound of the following structural formula (III) to produce a target product in high yield (about 87%).

Figure kpo00002
Figure kpo00002

본 발명을 좀더 상세히 설명하며, 물에 현탁된 구조식(II)화합물을 용해하여 액성을 조정할때, 염기의 양은 구조식(II)화합물 대비 1.5-4당량 사용하는 것이 좋으며, 이때 무기염기로는 중탄산나트륨, 탄산나트륨, 수산화나트륨, 수산화칼륨, 중탄산칼륨 또는 탄산칼륨등의 무기염기를 사용할 수 있으나 중탄산나트륨이 가장 바람직하고, 유기염기로는 티리에틸아민, 이디소프로필에틸아민등 3급아민유기염기를 사용할 수도 있으나 아세토니트릴이 가장 바람직하다. 아실화반응은 초기 pH가 8-9.5사이가 되도록 하여야 하고 반응 온도는 20-30℃에서 30분내에 반응시켜야 한다. 이는 아실화 도중 포밀기가 깨지는 것을 방지할 수 있고 목적물인 구조식(I)화합물의 카복실산에 구조식(Ⅲ)화합물이 반응하는 것을 막을 수 있기 때문이다.The present invention will be described in more detail, when dissolving the structural formula (II) compound suspended in water to adjust the liquidity, the amount of base is preferably used 1.5-4 equivalents to the structural formula (II) compound, wherein the inorganic base is sodium bicarbonate Inorganic bases such as sodium carbonate, sodium hydroxide, potassium hydroxide, potassium bicarbonate or potassium carbonate may be used, but sodium bicarbonate is most preferred, and organic amines such as tertiary amine organic base such as thiriethylamine and idiisopropylethylamine may be used. Acetonitrile may be used but is most preferred. The acylation reaction should be such that the initial pH is between 8-9.5 and the reaction temperature should be reacted at 20-30 ° C. within 30 minutes. This is because the formyl group can be prevented from being broken during acylation and the reaction of the structural formula (III) compound with the carboxylic acid of the structural formula (I) compound can be prevented.

본 발명의 또다른 목적은 구조식(II)화합물의 신규한 제조방법을 제공하고자 하는 것이다.Another object of the present invention is to provide a novel method for preparing the compound of formula II.

구조식(II)화합물의 새로운 제조방법으로, 산을 촉매로 사용하는 방법인데 농황산과 메탄설폰산의 혼합산을 촉매로 사용하거나, 삼불화붕소 에틸에테르착제(BF3O Et2)를 촉매로 사용하여 유기용매중 무수조건하에서 7-아미노 세팔로스포라닌산(7-ACA)의 아세톡시그룹을 1-메틸-1H-테트라졸-5-티올 친핵성 치환 반응시켜 비교적 간단한 공정으로 고수율로 얻는 방법이다.A new method for preparing the compound of formula (II), which uses acid as a catalyst, which uses a mixed acid of concentrated sulfuric acid and methanesulfonic acid as a catalyst, or uses boron trifluoride ethyl ether complex (BF 3 O Et 2 ) as a catalyst. 1-methyl-1H-tetrazol-5-thiol nucleophilic substitution reaction of acetoxy group of 7-amino cephalosporanic acid (7-ACA) under anhydrous conditions in an organic solvent to obtain a high yield in a relatively simple process. Way.

용매로는 아세트니트릴이 가장 좋은 결과를 얻을 수 있다.Acetonitrile is the best solvent.

상기의 본 발명은 선행기술과 비교해 볼때,Compared to the prior art of the present invention,

첫째, 아실화반응시 용매로 물을 사용하였으므로 모노트리메틸실릴 아세트아미드와 같은 고가의 실릴화제가 필요없고,First, since water is used as the solvent in the acylation reaction, no expensive silylating agent such as monotrimethylsilyl acetamide is required,

둘째, 고가의 3급아미드극성용매(1-메틸-2-피롤리디논)의 사용 및 수분제거제의 사용도 필요없으며,Secondly, there is no need to use expensive tertiary amide polar solvent (1-methyl-2-pyrrolidinone) and water remover.

셋째, 반응의 액성을 조절하여, 실릴화하지 않았음에도 부반응이 거의 없기때문에 목적물을 높은 수율로 얻을 수 있는 경제적인 방법인 것이다.Third, it is an economical way to obtain the target product in high yield because there is almost no side reaction even though it is not silylated by adjusting the liquidity of the reaction.

다음의 실시예들은 본 발명을 좀더 상세히 설명하기 위한 것이다.The following examples are intended to illustrate the invention in more detail.

[실시예 1]Example 1

7-아미노-3-(1-메틸-1H-테트라졸-5-일티오메틸)-3-세펨-4-카복실산의 합성.Synthesis of 7-amino-3- (1-methyl-1H-tetrazol-5-ylthiomethyl) -3-cepem-4-carboxylic acid.

30ml의 아세토니트릴에 2.72g(0.01mol)의 7-아미노세팔로스- 포라닌산과 1.33g(0.011mol)의 1-메틸-1H-테트라졸-5-티올을 현탁시키고, 10g의 농황산 및 2g의 메탄설폰산을 0℃이하에서 가한 다음 서서히 온도를 올려서 30℃에서 3시간 반응시킨후, 반응용액을 암모니아수로 pH를 3.8로 맞추고 동일온도에서 4시간 교반후, 여과하고 감압건조시키면 2.79g(84.8%)을 얻는다.2.72 g (0.01 mol) of 7-aminocephalos-foranic acid and 1.33 g (0.011 mol) of 1-methyl-1H-tetrazol-5-thiol are suspended in 30 ml of acetonitrile, and 10 g of concentrated sulfuric acid and 2 g of After adding methanesulfonic acid at 0 ° C or below, gradually raising the temperature and reacting at 30 ° C for 3 hours, adjusting the pH of the reaction solution to 3.8 with ammonia water, stirring at the same temperature for 4 hours, filtering and drying under reduced pressure, 2.79 g (84.8) %)

[실시예 2]Example 2

실시예 1에서 촉매로 사용한 황산과 메탄설폰산 대신 삼불화붕소에틸에테르착제(BF3OEt2)를 7.0g 사용하여 50℃에서 3시간 반응시켜 목적하는 화합물 7-아미노-3-(1-메틸-1-테트라졸-5-일티오메틸)-3-세펨-4-카복실산 3.03g(92%)을 얻는다.Instead of sulfuric acid and methanesulfonic acid used as catalysts in Example 1, 7.0 g of boron trifluoride ethyl ether complex (BF 3 OEt 2 ) was used to react at 50 ° C. for 3 hours to give the desired compound 7-amino-3- (1-methyl 3.03 g (92%) of 1-tetrazol-5-ylthiomethyl) -3-cepm-4-carboxylic acid are obtained.

[실시예 3]Example 3

7-아미노-3-(1-메틸-1H-테트라졸-5-일티오메틸)-3-세펨-4-카복실산 3.28g(0.01mol)을 물 60ml에 현탁시킨후 중탄산나트륨 1.51g을 가하여 1시간 교반한 다음 아세트니트릴 30ml을 가하여 pH를 8-9.5로 조정한다. 이 용액에 0-포밀만델로일클로라이드 2.11g(0.011mol)를 20-30℃의 실온에서 적하한후 30분 반응시킨 다음, 6N-HC1로 pH를 2로 조정한 후 에틸아세트 용매로 추출하여 망초로 건조하고 농축하여 7-(2-포밀옥시-2-페닐아세트아미드)-3-(1-메틸-1H-테트라졸-5-일티오메틸)-3-세펨-4-카복실산을 얻는다.3.28 g (0.01 mol) of 7-amino-3- (1-methyl-1H-tetrazol-5-ylthiomethyl) -3-cepem-4-carboxylic acid was suspended in 60 ml of water, and then 1.51 g of sodium bicarbonate was added thereto. After stirring for an hour, 30 ml of acetonitrile was added to adjust the pH to 8-9.5. 2.11 g (0.011 mol) of 0-formylmandeloyl chloride was added dropwise to the solution at 20-30 ° C. at room temperature, followed by reaction for 30 minutes. The pH was adjusted to 2 with 6N-HC1 and extracted with ethyl acetate solvent. To dryness and concentrated to give 7- (2-formyloxy-2-phenylacetamide) -3- (1-methyl-1H-tetrazol-5-ylthiomethyl) -3-cepem-4-carboxylic acid .

여기에 아세톤 30ml를 가하여 용매하고 나트륨-2-에틸헥사노에이트 1.7g을 아세톤 30ml에 녹인 용액을 상기 용액에 실온에서 30분에 걸쳐 적하한후 8시간 반응시킨 다음 -8℃로 냉가 여과하고 45℃에서 감압건조하면 4.45g의 백색7-(2-포밀옥시-2-페닐아세트아미도)-3-(1-메틸-1-테트라졸-5-일티오메틸)-3-세펨-4-카복실산나트륨염을 얻는다.30 ml of acetone was added to the solvent, and a solution of 1.7 g of sodium-2-ethylhexanoate in 30 ml of acetone was added dropwise to the solution over 30 minutes at room temperature, and then reacted for 8 hours. 4.45 g of white 7- (2-formyloxy-2-phenylacetamido) -3- (1-methyl-1-tetrazol-5-ylthiomethyl) -3-cepem-4- when dried under reduced pressure at 占 폚. Sodium carboxylate salt is obtained.

수율 87%Yield 87%

Figure kpo00003
Figure kpo00003

[실시예 4]Example 4

실시예 3의 아실화 공정에서 용매를 디메틸포름아미이드를 사용할 경우, 목적하는 화합물 7-(2-포밀옥시-2-페닐아세트아미도)-3-(1-메틸-1H-테트라졸-5-일티오메틸)-3-세펨-4-카복실산나트륨 4.2g을 얻는다. 수율 82%When dimethylformamide is used as the solvent in the acylation process of Example 3, the desired compound 7- (2-formyloxy-2-phenylacetamido) -3- (1-methyl-1H-tetrazol-5 4.2 g of sodium thiomethyl) -3-cefe-4-carboxylic acid is obtained. Yield 82%

[실시예 5]Example 5

실시예 3에서 중탄산나트륨 대신 트리에틸아민을 사용했을 경우, 목적하는 화합물 7-(2-포밀옥시-2-페닐아세트아미도)-3-(1-메틸-1H-테트라졸-5-일티오메틸)-3-세펨-4-카복실산나트륨염 3.8g을 얻는다. 수율 74%When triethylamine was used instead of sodium bicarbonate in Example 3, the desired compound 7- (2-formyloxy-2-phenylacetamido) -3- (1-methyl-1H-tetrazol-5-ylthio 3.8 g of methyl) -3-cefe-4-carboxylic acid sodium salt are obtained. Yield 74%

Claims (1)

구조식(II)화합물을 제조함에 있어서, 7-아미노세팔로스포라닌산과틸-1H-테트라졸-5-티올을 아세토니트릴 유기용매중 무수조건하에서 삼불화붕소에텔에테착체 (BF3OEt2)를 촉매로 하여 반응시킴을 특징으로 하는 구조식(II)화합물의 제조방법.In preparing the compound of formula II, boron trifluoride ether ether complex (BF 3 OEt 2 ) with 7-aminocephalosporanic acid gutyl-1H-tetrazol-5-thiol under anhydrous conditions in an acetonitrile organic solvent Process for producing a compound of formula (II) characterized in that the reaction with a catalyst.
Figure kpo00004
Figure kpo00004
KR1019900011992A 1990-08-06 1990-08-06 Process for preparing cephalosporin derivatives KR930007419B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019900011992A KR930007419B1 (en) 1990-08-06 1990-08-06 Process for preparing cephalosporin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019900011992A KR930007419B1 (en) 1990-08-06 1990-08-06 Process for preparing cephalosporin derivatives

Publications (2)

Publication Number Publication Date
KR920004400A KR920004400A (en) 1992-03-27
KR930007419B1 true KR930007419B1 (en) 1993-08-10

Family

ID=19302031

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900011992A KR930007419B1 (en) 1990-08-06 1990-08-06 Process for preparing cephalosporin derivatives

Country Status (1)

Country Link
KR (1) KR930007419B1 (en)

Also Published As

Publication number Publication date
KR920004400A (en) 1992-03-27

Similar Documents

Publication Publication Date Title
EP0175814B1 (en) Process for preparing cephem derivatives
KR20040008158A (en) Process for the preparation of cefpodoxime acid
US4148817A (en) Process and intermediates for preparing cephalosporin antibiotics
KR930007419B1 (en) Process for preparing cephalosporin derivatives
US3769281A (en) Deblocking process for cephalosporin antibiotics
US20070004916A1 (en) Process for the production of cefotaxime sodium
US5302713A (en) Method for the preparation of Δ3 -7-substituted amino desacetoxy cephalosporanic acid
EP0019067B1 (en) 5,10-dioxo-5,10-dihydrodiimidazo(1,5-a,1',5'-d)pyrazine-1,6-dicarboxylic acid and a process for producing imidazoledicarboxylic acid amido-derivatives
US3671449A (en) Cephalosporin compositions
RO109652B1 (en) Hydrate dihydrochloride cefepim antibiotic preparation process
SU1245262A3 (en) Method of producing 1-ethoxycarbonyloethyl ester of 6-/d-(-)-2-amino-2-phenylacetamido/-penicillanic acid as its additive salt with halogen acid
EP0023045B1 (en) Imidazolecarboxylic acid derivatives of penicillins and cephalosporins
US5081248A (en) Pyridine-n-oxide derivative
SU440842A1 (en)
SU603341A3 (en) Method of preparing cephalosporins
KR820001564B1 (en) Process for preparing cephalosporin derivatives
KR830001969B1 (en) 6- {D-(-) α- (4-ethyl-2.3-dioxo-1 piperazinocarbonylamino) phenyl (or hydroxyphenyl) acetamido peniclanic acid and a method for preparing the salt thereof
US5003064A (en) Method for the preparation of monohydrate
US5552542A (en) Preparation and use of 7-[(2-carboalkoxy-1-methylethenyl)amino]-3-hydroxymethyl-3-cephem-4-carboxylic acids
US3868364A (en) Improved process for producing penicillin compound
KR830002896B1 (en) Process for preparing cephalosporin derivatives
US4223134A (en) Process for preparing cephalosporin antibiotics
KR910001007B1 (en) Penicillanic acid and cephalosporin derivatives
CA1095025A (en) Process for preparing 2-acyloxymethylpenams and 3- acyloxy-cephams
US20040077849A1 (en) Process for the preparation of cefadroxil

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

G160 Decision to publish patent application
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19951215

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee